Showing 6511-6520 of 20414 results for "".
The Use of TORS for HPV-Related Oropharynx Cancer
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/the-use-of-tors-for-hpv-related-oropharynx-cancer/7251/Oropharyngeal cancer is part of a growing proportion of head and neck malignancies. This has also been associated with the increase in infection of the oropharynx by oncogenic strains of the human papillomavirus (HPV). And, transoral robotic surgery, or TORS, has allowed for minimally invasive surgeSystemic Hormonal Therapy Options for Post-Menopausal Patients
https://reachmd.com/programs/clinicians-roundtable/systemic-hormonal-therapy-options-for-post-menopausal-patients/7215/Post-menopausal patients have many options and choices for hormone therapy. But what are the issues and increased risks, if any? What are the latest updates from recent hormone therapy clinical trials and how does this impact clinical practice? Host Dr. Prathima Setty welcomes Dr. JoAnn V. PinkertonControversies in the Use of Progestogens for Prevention of Preterm Birth
https://reachmd.com/programs/clinicians-roundtable/controversies-in-the-use-of-progestogens-for-prevention-of-preterm-birth/7020/What does the current evidence tell clinicians about the use of progestogens for prevention of preterm birth (PTB)? How should women with a previous spontaneous PTB be evaluated for risk of subsequent PTB? And what interventions have been shown to be beneficial for reducing the risk of PTB in womenEverything Below the Belt: The Women's Health Foundation's Pelvic Health Mission
https://reachmd.com/programs/partners-in-practice/everything-below-the-belt-the-womens-health-foundations-pelvic-health-mission/6998/Host Mimi Secor welcomes Women's Health Foundation founder and Executive Director, Missy Lavender, to talk about innovative ways to bring women into pelvic health programs across the U.S. Through her foundation, Ms. Lavender helps address issues of ignorance and intimidation that often pervade bothEarly Detection of Alzheimer's: Where Do We Go From Here?
https://reachmd.com/programs/advances-in-long-term-care-medicine/early-detection-of-alzheimers-where-do-we-go-from-here/6015/Early detection of various conditions can help physicians better manage and treat their patients, and Alzheimer's is no exception. What early screening tests of cognitive impairment or dementia should be administered by primary care providers help detect when the disease process is beginning? Dr. JaUMMA Clinic: Bridging Cultural Divides Through Health Care
https://reachmd.com/programs/clinicians-roundtable/umma-clinic-bridging-cultural-divides-through-health-care/4615/In 1992, after the verdict was handed down in the Rodney King trial, there were six days of rioting in south Los Angeles. Thousands were injured, more than 50 people were killed, and the city saw approximately one billion dollars in property damage. One of the few bright spots during this dark timeTissue-Engineered Trachea Transplantation
https://reachmd.com/programs/focus-on-future-medicine-and-genetics/tissue-engineered-trachea-transplantation/4105/Recently, scientists were able to engineer for the first time a trachea developed from a patient's own stem cells, wherein a donor's trachea was lined with the patient's stem cells to prevent transplant rejection. Immunosuppressive therapy was not necessary, and the patient remains in good conditionThe Role of Allergists at the Grassroots of Medicine and Public Health
https://reachmd.com/programs/hot-topics-in-allergy/the-role-of-allergists-at-the-grassroots-of-medicine-public-health/4027/How are Medicare and health insurance companies affecting physicians and their patients' access to care? What can physicians do to influence policy at the local level? Dr. J. Allen Meadows, clinical instructor in the Montgomery Internal Medicine Residency Program at the University of Alabama at BirmProstate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?
https://reachmd.com/programs/clinicians-roundtable/prostate-cancer-predictability-can-we-anticipate-patients-risk-25-years/2987/Can you predict a man’s risk of prostate cancer 25 years in the future? The data from this study indicates that PSA levels before age 50 is an indicator of future prostate cancer. Find out more about the prospective study conducted by a team of researchers from Memorial Sloane Kettering. EpidemiologCDC Response to MRSA
https://reachmd.com/programs/clinicians-roundtable/cdc-response-to-mrsa/2024/Our guest, Dr. John Jernigan discusses the CDC's response to MRSA with host, Dr. Bill Rutenberg. Topics included: resources available, education & training, measuring impact and measuring adhearance.